Trinity Point Wealth, LLC Gilead Sciences, Inc. Transaction History

Trinity Point Wealth, LLC

$680 Million
Q3 2024

A detailed history of Trinity Point Wealth, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Trinity Point Wealth, LLC holds 43,606 shares of GILD stock, worth $4.1 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

43,606

Previous 5,749 658.5%

Holding current value

$4.1 Million

Previous $394,000 827.66%

% of portfolio

0.54%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$66.59 - $83.99 $2.52 Million - $3.18 Million	37,857 Added 658.5%	43,606 $3.66 Million
Q2 2024 Jul 30, 2024	SELL	$63.15 - $72.88 $8,651 - $9,984	-137 Reduced 2.33%	5,749 $394,000
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $12,741 - $15,537	178 Added 3.12%	5,886 $431,000
Q4 2023 Feb 08, 2024	BUY	$73.27 - $83.09 $11,649 - $13,211	159 Added 2.87%	5,708 $462,000
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $1,109 - $1,210	15 Added 0.27%	5,549 $415,000
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $24,475 - $27,917	-322 Reduced 5.5%	5,534 $426,000
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $5,102 - $5,813	66 Added 1.14%	5,856 $485,000
Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $39,697 - $56,992	637 Added 12.36%	5,790 $497,000
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $17,981 - $20,539	302 Added 6.23%	5,153 $318,000
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $1,904 - $2,145	33 Added 0.68%	4,851 $300,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $521 - $653	9 Added 0.19%	4,818 $286,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $7,526 - $8,542	116 Added 2.47%	4,809 $349,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $14,688 - $15,847	217 Added 4.85%	4,693 $328,000
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $8,251 - $9,015	130 Added 2.99%	4,476 $308,000
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $3,240 - $3,696	-54 Reduced 1.23%	4,346 $281,000
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $16,031 - $18,267	283 Added 6.87%	4,400 $293,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $3,912 - $4,919	63 Added 1.55%	4,117 $260,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $27,923 - $32,424	-386 Reduced 8.69%	4,054 $312,000
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $1.07 Million - $1.37 Million	-17,026 Reduced 79.32%	4,440 $332,000
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $10,721 - $11,793	174 Added 0.82%	21,466 $1.4 Million
Q3 2019 Nov 07, 2019	BUY	$62.51 - $69.0 $9,063 - $10,005	145 Added 0.69%	21,292 $1.39 Million
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $2,598 - $2,913	-42 Reduced 0.2%	21,147 $1.41 Million
Q1 2019 May 07, 2019	BUY	$62.53 - $70.05 $527,378 - $590,801	8,434 Added 66.12%	21,189 $1.38 Million
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $772,187 - $1.01 Million	12,755 New	12,755 $798,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Point Wealth, LLC with notifications on news.

Account

Trinity Point Wealth, LLC Gilead Sciences, Inc. Transaction History